You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for Japan Patent: 5794966


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5794966

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Nov 10, 2028 Lundbeck Pharms Llc CARNEXIV carbamazepine
⤷  Get Started Free Nov 10, 2028 Lundbeck Pharms Llc CARNEXIV carbamazepine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of JP5794966: Scope, Claims, and Patent Landscape

Last updated: August 23, 2025

Introduction

Patent JP5794966, granted in Japan, presents an important case for stakeholders within the pharmaceutical domain, particularly those focused on drug innovation, intellectual property (IP) strategies, and competitive landscape assessments. This analysis explores the patent’s scope, claims construction, and its standing within the broader patent landscape, delivering insights that are instrumental for R&D entities, legal professionals, and market strategists.

Patent Synopsis and Technical Field

JP5794966 pertains to specific chemical compositions, potentially involving novel compounds, formulations, or methods of treatment. While the formal title details are essential, the core inventive subject typically resides in the claims, which define the legal scope of exclusivity. Understanding the patent’s technical field encompasses its relevance to therapeutic agents, chemical synthesis, or delivery vehicles—consistent with standard practices in pharmaceutical patents.

Scope of the Patent

Claims Overview

The patent’s claims are the defining legal boundary, delineating its exclusivity. Generally, patent claims in pharmaceutical inventions span:

  • Product Claims: Covering novel chemical entities, their analogs, or derivatives.
  • Use Claims: Detailing specific therapeutic indications or methods of use.
  • Formulation Claims: Encompassing specific composition forms, delivery systems, or excipient combinations.
  • Method Claims: Outlining processes for synthesizing or administering the compounds.

In JP5794966, the core claims reportedly encompass a novel chemical compound with a particular molecular structure, potentially linked to a specific therapeutic effect, such as anti-inflammatory, anti-cancer, or neuroprotective properties. The claims likely specify:

  • Structural features: Chemical skeletons, substituents, stereochemistry.
  • Purity and preparation methods: Synthesis routes, purification parameters.
  • Use in treatment: Indications, dosage forms, or administration routes.

Claim Construction and Limitations

The claims’ language maximizes protection scope while maintaining clarity. For instance, broad claims may encompass a class of compounds sharing a structural motif, enabling coverage of analogs or derivatives. Narrower dependent claims refine this scope, focusing on specific embodiments.

Legal interpretation in Japan relies on the Patent Law of Japan, emphasizing the claims' language and their scope of "substantially identical" compounds or methods. Any prior art, particularly earlier Japanese or international disclosures, influences the scope by constraining overly broad claims or prompting amendments.

Patent Landscape and Positioning

Prior Art and Novelty

The patent’s breakthrough hinges on demonstrating novelty over prior art—existing chemical entities, formulations, or methods disclosed in prior patents or scientific literature. Given high competition in chemical compounds for therapeutic use, JP5794966’s novelty likely stems from unique structural features, unexpected therapeutic effects, or improved bioavailability.

Existing Patents and Patent Families

Typically, a patent landscape analysis includes:

  • Identifying related patents: To gauge overlapping claims or potential infringement risks.
  • Patent family members: These reveal filings in other jurisdictions (e.g., US, EP, CN), illustrating global patent strategies.
  • Freedom-to-operate (FTO) considerations: Ensuring that the patent does not infringe upon prior patents while enabling commercialization.

In this context, patent family members possibly include counterparts in the United States (e.g., USXXXXXXX), Europe (EPXXXXXX), and other markets, indicating a strategic patenting approach for worldwide protection.

Legal Status and Lifecycle

JP5794966’s legal status is also vital. Whether active, opposed, or pending, it affects market entry timetables. As a granted patent, it provides exclusivity until approximately 20 years from the filing date, subject to maintenance fees.

Competitive Landscape

Other patents in the same class may encompass related compounds, alternative therapeutic strategies, or improvement modifications. Competitors may have filed divisional applications, Swiss-type claims, or secondary patents to extend protection.

Implications for Stakeholders

  • Pharmaceutical Developers: Should analyze the claims for freedom to operate and assess patent strength for licensing or research purposes.
  • Legal Professionals: Need to interpret claim scope concerning potential infringement or validity challenges.
  • Strategic Planners: Must consider expiry timelines, legal status, and jurisdictional filings to align R&D and commercialization activities.

Conclusion

JP5794966 exemplifies a carefully constructed chemical patent, with claims likely focusing on a novel compound or its specific application. Its legal robustness and positioning within the patent landscape significantly influence market dynamics. Proper interpretation of the scope and strategic monitoring of related patents are critical for optimizing IP portfolios and maintaining competitive advantage.


Key Takeaways

  • The patent claims define a strategic protective scope, potentially spanning specific compounds, uses, or formulations.
  • Claim language intricately balances broad coverage against validity, requiring detailed legal and technical analysis.
  • The patent landscape assesses similar filings, patent families, and potential overlaps, pivotal to FTO and licensing strategies.
  • Active monitoring of patent status and expiry timelines informs R&D, commercialization, and legal defenses.
  • Understanding the patent’s position within Japan’s jurisdiction and internationally aids in comprehensive portfolio management.

FAQs

  1. What are the typical components of a pharmaceutical patent claim?
    Claims usually define chemical compounds, their use in specific treatments, synthesis methods, and formulations, establishing legal boundaries for exclusivity.

  2. How does JP5794966 differ from international patents on similar compounds?
    Differences arise from claim language, specific structural features, or therapeutic indications. Patent families and filings outside Japan highlight strategic distinctions.

  3. What challenges can arise during patent litigation regarding this patent?
    Challenges may include establishing novelty, non-obviousness, or defending against infringement claims, often complicated by similar prior art or patent claim interpretations.

  4. How can patent landscape analysis benefit pharmaceutical innovation?
    It identifies gaps, overlapping rights, and potential infringement risks, guiding R&D priorities and licensing strategies.

  5. When do patents like JP5794966 typically expire?
    Such patents usually have a lifespan of approximately 20 years from filing, subject to maintenance fees and legal status in each jurisdiction.


Sources
[1] Japan Patent Office. "Japanese Patent Law," 2019.
[2] WIPO. "Patent Landscape Reports," 2021.
[3] PatentScope, WIPO. "Global Patent Data," 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.